Fosamax and Vyvanse drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosamax (alendronate sodium) and Vyvanse (lisdexamfetamine dimesylate). Common drug interactions include gastroenteritis viral among females and pulmonary oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Fosamax and Vyvanse. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.



On Aug, 04, 2026

27 people who take Fosamax and Vyvanse together, and have interactions are studied.

Fosamax and Vyvanse drug interactions.

What are the common drug interactions of Fosamax and Vyvanse, by gender? *:

female:

  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Glucose urine present
  3. Infusion related reaction
  4. Intestinal obstruction
  5. Micturition disorder (disease of passing urine)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nocturia (the need to get up in the night to urinate)
  8. Rectal discharge (discharge from rectum)
  9. Respiratory rate decreased (less breathing rate/min)
  10. Rhinorrhoea (watery mucus discharge from the nose)

male:

  1. Pulmonary oedema (fluid accumulation in the lungs)
  2. Abdominal pain
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  5. Cerebral calcification (abnormal deposits of calcium in certain areas of the brain)
  6. Cerebral infarction (less blood supply to brain resulting tissue damage)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Conjunctival haemorrhage (bleeding underneath the conjunctiva)
  9. Death
  10. Decreased appetite

What are the common drug interactions of Fosamax and Vyvanse, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  2. Lymphoedema (localized fluid retention and tissue swelling)
  3. Metastases to bone (cancer spreads to bone)
  4. Metastases to spine (cancer spreads to spine)
  5. Micturition disorder (disease of passing urine)
  6. Micturition urgency (urgency to pass the urine)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Nausea (feeling of having an urge to vomit)
  9. Nocturia (the need to get up in the night to urinate)
  10. Oedema peripheral (superficial swelling)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Fall
  2. Arthralgia (joint pain)
  3. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  4. Pain
  5. Apathy
  6. Asthenia (weakness)
  7. Blood pressure systolic increased
  8. Chronic kidney disease
  9. Drug effect decreased
  10. Drug effect increased

60+:

  1. Cough
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal injury (kidney injury)
  5. Swelling face
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Weight increased
  8. Blood pressure increased
  9. Chronic kidney disease
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the existing conditions these people have? *

  1. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 14.81%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 14.81%
  3. Depression: 4 people, 14.81%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 14.81%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.11%
  6. Stress And Anxiety: 2 people, 7.41%
  7. Migraine (headache): 2 people, 7.41%
  8. High Blood Pressure: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Fosamax and Vyvanse?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fosamax and Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fosamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fosamax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyvanse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on alendronate sodium and lisdexamfetamine dimesylate (the active ingredients of Fosamax and Vyvanse, respectively), and Fosamax and Vyvanse (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: